217 related articles for article (PubMed ID: 17468771)
21. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
22. Successful second autologous peripheral blood stem cell transplantation conditioned with total body irradiation for progressive neuroblastoma after recurrence.
Morimoto T; Matsufuji H; Yokomori K; Hosoya R
Tokai J Exp Clin Med; 2006 Dec; 31(4):154-6. PubMed ID: 21302246
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
[TBL] [Abstract][Full Text] [Related]
24. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
Sung KW; Yoo KH; Chung EH; Cho EJ; Jung HL; Koo HH; Lee SK; Lim DH; Kim DY; Kim DW; Kim HR; Kim SW
J Korean Med Sci; 2002 Aug; 17(4):537-43. PubMed ID: 12172052
[TBL] [Abstract][Full Text] [Related]
25. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis.
Greb A; Bohlius J; Trelle S; Schiefer D; De Souza CA; Gisselbrecht C; Intragumtornchai T; Kaiser U; Kluin-Nelemans HC; Martelli M; Milpied NJ; Santini G; Verdonck LF; Vitolo U; Schwarzer G; Engert A
Cancer Treat Rev; 2007 Jun; 33(4):338-46. PubMed ID: 17400393
[TBL] [Abstract][Full Text] [Related]
26. High-dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy.
Delafoy M; Verschuur A; Scheleirmacher G; Tabone MD; Sudour-Bonnange H; Thébaud E; Freycon C; Notz-Carrère A; Boulanger C; Pellier I; Irtan S; Muracciole X; Coulomb-L'Hermine A; Dijoud F; Morelle M; Bergeron C; Pasqualini C
Pediatr Blood Cancer; 2022 Mar; 69(3):e29431. PubMed ID: 34811873
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
[TBL] [Abstract][Full Text] [Related]
28. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
29. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
[TBL] [Abstract][Full Text] [Related]
30. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
Ballova V; Ladicka M; Vranovsky A; Lakota J
Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
[TBL] [Abstract][Full Text] [Related]
31. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
[TBL] [Abstract][Full Text] [Related]
32. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
[TBL] [Abstract][Full Text] [Related]
33. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis.
Presson A; Moore TB; Kempert P
J Pediatr Hematol Oncol; 2010 Aug; 32(6):454-61. PubMed ID: 20505538
[TBL] [Abstract][Full Text] [Related]
35. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
J Korean Med Sci; 2017 Feb; 32(2):195-203. PubMed ID: 28049229
[TBL] [Abstract][Full Text] [Related]
36. Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapy.
Simon T; Hero B; Faldum A; Handgretinger R; Schrappe M; Niethammer D; Berthold F
Klin Padiatr; 2005; 217(3):147-52. PubMed ID: 15858706
[TBL] [Abstract][Full Text] [Related]
37. Renal function after tandem high-dose chemotherapy and autologous stem cell transplantation in children with Wilms tumor.
Lee SH; Paik KH; Sung KW; Son MH; Yoo KH; Koo HH; Kim JY; Cho EJ
Pediatr Transplant; 2011 Dec; 15(8):855-60. PubMed ID: 22060039
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
39. [Treatment results of neuroblastoma in children in the Republic of Belarus].
Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
[TBL] [Abstract][Full Text] [Related]
40. Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion.
Ladenstein R; Pötschger U; Siabalis D; Garaventa A; Bergeron C; Lewis IJ; Stein J; Kohler J; Shaw PJ; Holter W; Pistoia V; Michon J
J Clin Oncol; 2011 Feb; 29(4):441-8. PubMed ID: 21149662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
